eltrombopag olamine
SpainDrugs containing this active substance
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune (primary) thrombocytopenia in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,90 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune (primary) thrombocytopenia in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,80 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune (primary) thrombocytopenia in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection who have had problems with interferon treatment.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 95,70 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,90 mg Manufacturer: Reddy Pharma Iberia S.A.
-
It is used to help increase the number of platelets in the blood. It is used to treat immune (primary) thrombocytopenia in patients over 1 year of age who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,80 mg Manufacturer: Reddy Pharma Iberia S.A.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with interferon treatment.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 95,70 mg Manufacturer: Reddy Pharma Iberia S.A.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients aged 1 year or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with interferon-based treatment.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,90 mg Manufacturer: Glenmark Arzneimittel Gmbh
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients aged 1 year or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with interferon-based therapy.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,80 mg Manufacturer: Glenmark Arzneimittel Gmbh
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (primary) in patients 1 year of age or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,90 mg Manufacturer: Kern Pharma S.L.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients 1 year of age or older who have not responded to other medicines, and also to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with interferon treatment.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,80 mg Manufacturer: Kern Pharma S.L.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients 1 year of age or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with the adverse effects of interferon treatment.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 95,70 mg Manufacturer: Kern Pharma S.L.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,903 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with the adverse effects of interferon treatment.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,806 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat (primary) immune thrombocytopenia in patients over 1 year of age who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,901 mg Manufacturer: Tarbis Farma S.L.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,802 mg Manufacturer: Tarbis Farma S.L.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients 1 year of age or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with the adverse effects of interferon treatment.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,900 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients 1 year of age or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,800 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients 1 year of age or older who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with the adverse effects of interferon treatment.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 95,700 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,90 mg Manufacturer: Viatris Limited
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection who have experienced problems with interferon side effects.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,80 mg Manufacturer: Viatris Limited
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,9 mg Manufacturer: Vivanta Generics S.R.O.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection who have experienced problems with the adverse effects of interferon treatment.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,8 mg Manufacturer: Vivanta Generics S.R.O.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection who have experienced problems with the adverse effects of interferon treatment.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 95,7 mg Manufacturer: Vivanta Generics S.R.O.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune (primary) thrombocytopenia in patients 1 year of age or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,90 mg Manufacturer: Zentiva K.S.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune (primary) thrombocytopenia in patients 1 year of age or older who have not responded to other medications, and to treat low platelet levels in adults with hepatitis C virus infection.
Form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,8 mg Manufacturer: Zentiva K.S.